Upgrade to SI Premium - Free Trial

Neurocrine Bio. (NBIX) PT Raised to $100 at Baird After Another Beat for Ingrezza

May 1, 2018 7:15 AM
Baird raised its price target on Neurocrine Bio. (NASDAQ: NBIX) to $100.00 (from $84.00) while maintaining an Outperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles